Amy C. H. Lee

3.1k total citations
18 papers, 1.1k citations indexed

About

Amy C. H. Lee is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Amy C. H. Lee has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 10 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in Amy C. H. Lee's work include Hepatitis B Virus Studies (12 papers), RNA Interference and Gene Delivery (7 papers) and Hepatitis C virus research (7 papers). Amy C. H. Lee is often cited by papers focused on Hepatitis B Virus Studies (12 papers), RNA Interference and Gene Delivery (7 papers) and Hepatitis C virus research (7 papers). Amy C. H. Lee collaborates with scholars based in United States, New Zealand and South Korea. Amy C. H. Lee's co-authors include Ian MacLachlan, Adam D. Judge, Thomas W. Geisbert, Joan B. Geisbert, Emily P. Thi, Chad E. Mire, Krystle N. Agans, Karla A. Fenton, Daniel J. Deer and Nicholas M. Snead and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Journal of Virology.

In The Last Decade

Amy C. H. Lee

18 papers receiving 1.1k citations

Peers

Countries citing papers authored by Amy C. H. Lee

Since Specialization

Citations

This map shows the geographic impact of Amy C. H. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy C. H. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy C. H. Lee more than expected).

Fields of papers citing papers by Amy C. H. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy C. H. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy C. H. Lee. The network helps show where Amy C. H. Lee may publish in the future.

Co-authorship network of co-authors of Amy C. H. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Amy C. H. Lee. A scholar is included among the top collaborators of Amy C. H. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy C. H. Lee. Amy C. H. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Rational Design, Synthesis, and Structure–Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836 2024 ·Journal of Medicinal Chemistry ·Andrew G. Cole, Steven G. Kultgen, Nagraj Mani, Kristi Fan, (unknown), (unknown), Bruce D. Dorsey, Eugen F. Mesaros, Emily P. Thi, (unknown), (unknown), Troy O. Harasym, Amy C. H. Lee, Andrea Olland, R.K. Suto, Michael J. Sofia	4
2	Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA Therapeutic 2024 ·ACS Infectious Diseases ·Emily P. Thi, Xin Ye, Nicholas M. Snead, Amy C. H. Lee, Holly M. Micolochick Steuer, (unknown), (unknown), Christine Espiritu, Andrea Cuconati, (unknown), (unknown), (unknown), Bhavna Paratala, Kevin McClintock, Troy O. Harasym, René Rijnbrand, Angela M. Lam, Michael J. Sofia	6
3	Structure–Activity Relationships and Discovery of (S)-6-Isopropyl-2-methoxy-3-(3-methoxypropoxy)-10-oxo-5,10-dihydro-6H-pyrido[1,2-h][1,7]naphthyridine-9-carboxylic Acid (AB-452), a Novel Orally Available HBV RNA Destabilizer 2024 ·Journal of Medicinal Chemistry ·(unknown), Bruce D. Dorsey, (unknown), (unknown), (unknown), (unknown), Min Gao, (unknown), Fei Liu, Troy O. Harasym, Tim Chiu, (unknown), Amy C. H. Lee, Andrew G. Cole, Michael J. Sofia	4
4	Design, synthesis, and structure-activity relationship of a bicyclic HBV capsid assembly modulator chemotype leading to the identification of clinical candidate AB-506 2023 ·Bioorganic & Medicinal Chemistry Letters ·Andrew G. Cole, Steven G. Kultgen, Nagraj Mani, (unknown), Kristi Fan, (unknown), (unknown), Bruce D. Dorsey, Janet R. Phelps, Amy C. H. Lee, Emily P. Thi, Tim Chiu, (unknown), P.S. Horanyi, Stephen J. Mayclin, Troy O. Harasym, Michael J. Sofia	4
5	Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB‐506 from Phase 1 studies in healthy subjects and those with hepatitis B 2022 ·Hepatology Communications ·Man‐Fung Yuen, Elina Berliba, Wattana Sukeepaisarnjaroen, Sang Hoon Ahn, Tawesak Tanwandee, Young‐Suk Lim, Yoon Jun Kim, Kittiyod Poovorawan, Pisit Tangkijvanich, Christian Schwabe, Timothy Eley, J. B. Brown, Amy C. H. Lee, Emily P. Thi, Bhavna Paratala, Nagraj Mani, Michael J. Sofia, Gastón Picchio, Karen Sims, Edward Gane	17
6	Ligand conjugate SAR and enhanced delivery in NHP 2021 ·Molecular Therapy ·(unknown), Kieu Lam, Xin Ye, A. D. Martin, (unknown), Lorne Palmer, David Fraser, Kevin McClintock, (unknown), (unknown), Amy C. H. Lee, Emily P. Thi, Adam D. Judge, James Heyes	8
7	Host Poly(A) Polymerases PAPD5 and PAPD7 Provide Two Layers of Protection That Ensure the Integrity and Stability of Hepatitis B Virus RNA 2021 ·Journal of Virology ·Fei Liu, Amy C. H. Lee, Fang Guo, Andrew S. Kondratowicz, Holly M. Micolochick Steuer, (unknown), (unknown), Xiaohe Wang, (unknown), Steven G. Kultgen, Andrea Cuconati, Andrew G. Cole, (unknown), Bruce D. Dorsey, René Rijnbrand, Angela M. Lam, Michael J. Sofia, Min Gao	18
8	Hepatitis B virus core protein variants observed in a first-in-human placebo-controlled study of a core protein inhibitor 2020 ·Journal of Hepatology ·Amy C. H. Lee, Emily P. Thi, (unknown), J. B. Brown, Timothy Eley, Nagraj Mani, René Rijnbrand, Karen Sims, Michael J. Sofia, Gastón Picchio	3
9	FRI-184-Function and drug combination studies in cell culture models for AB-729, a subcutaneously administered siRNA investigational agent for chronic hepatitis B infection 2019 ·Journal of Hepatology ·Amy C. H. Lee, Emily P. Thi, Andrea Cuconati, (unknown), (unknown), Hui Huang, Andrew S. Kondratowicz, (unknown), Lorne Palmer, (unknown), René Rijnbrand, Holly M. Micolochick Steuer, Xiaohe Wang, Xin Ye, Michael J. Sofia	7
10	ARB-1740, a RNA Interference Therapeutic for Chronic Hepatitis B Infection 2018 ·ACS Infectious Diseases ·Emily P. Thi, (unknown), (unknown), (unknown), (unknown), Andrea Cuconati, Andrew S. Kondratowicz, (unknown), (unknown), (unknown), (unknown), (unknown), Janet R. Phelps, Nicholas M. Snead, Xiaohe Wang, Xin Ye, Michael J. Sofia, Amy C. H. Lee	46
11	Hepatitis B Virus Therapeutic Agent ARB-1740 Has Inhibitory Effect on Hepatitis Delta Virus in a New Dually-Infected Humanized Mouse Model 2018 ·ACS Infectious Diseases ·Xin Ye, Chise Tateno, Emily P. Thi, Masakazu Kakuni, Nicholas M. Snead, Yuji Ishida, Trisha R. Barnard, Michael J. Sofia, Takashi Shimada, Amy C. H. Lee	22
12	siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease 2017 ·Journal of Clinical Investigation ·Emily P. Thi, Chad E. Mire, Amy C. H. Lee, Joan B. Geisbert, Raùl Ursic-Bedoya, Krystle N. Agans, Marjorie Robbins, Daniel J. Deer, Robert W. Cross, Andrew S. Kondratowicz, Karla A. Fenton, Ian MacLachlan, Thomas W. Geisbert	27
13	Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates 2016 ·The Journal of Infectious Diseases ·Chad E. Mire, Joan B. Geisbert, Krystle N. Agans, Emily P. Thi, Amy C. H. Lee, Karla A. Fenton, Thomas W. Geisbert	32
14	Rescue of non-human primates from advanced Sudan ebolavirus infection with lipid encapsulated siRNA 2016 ·Nature Microbiology ·Emily P. Thi, Amy C. H. Lee, Joan B. Geisbert, Raùl Ursic-Bedoya, Krystle N. Agans, Marjorie Robbins, Daniel J. Deer, Karla A. Fenton, Andrew S. Kondratowicz, Ian MacLachlan, Thomas W. Geisbert, Chad E. Mire	43
15	Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates 2015 ·Nature ·Emily P. Thi, Chad E. Mire, Amy C. H. Lee, Joan B. Geisbert, Joy Zhou, Krystle N. Agans, Nicholas M. Snead, Daniel J. Deer, Trisha R. Barnard, Karla A. Fenton, Ian MacLachlan, Thomas W. Geisbert	190
16	Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA 2014 ·Science Translational Medicine ·Emily P. Thi, Chad E. Mire, Raùl Ursic-Bedoya, Joan B. Geisbert, Amy C. H. Lee, Krystle N. Agans, Marjorie Robbins, Daniel J. Deer, Karla A. Fenton, Ian MacLachlan, Thomas W. Geisbert	62
17	Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA Interference 2006 ·The Journal of Infectious Diseases ·Thomas W. Geisbert, Lisa E. Hensley, Elliott Kagan, Erik Z. Yu, Joan B. Geisbert, Kathleen M. Daddario-DiCaprio, Elizabeth A. Fritz, Peter B. Jahrling, Kevin McClintock, Janet R. Phelps, Amy C. H. Lee, Adam D. Judge, Lloyd B. Jeffs, Ian MacLachlan	181
18	Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo 2005 ·Molecular Therapy ·Adam D. Judge, (unknown), Amy C. H. Lee, Ian MacLachlan	437

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact